TFEB and metabolic dysfunction-associated steatotic liver disease: Moreover, pharmacological TFEB activation improves hepatic lipid accumulation and β-oxidation in diet-induced NAFLD animal models (Sinha et al., 2014; Zhou et al., 2014).